Lipum, акция обыкновенная (SE0021922598, LIPUM BTA)

Lipum AB is a biopharmaceutical company. It specializes in the discovery and development of new treatment for chronic inflammatory diseases. The drug candidate SOL-116 is a humanized antibody that aims to provide safer and more effective treatment by blocking a previously overlooked target molecule (BSSL) in the immune system.

• Lipum, акция обыкновенная, SE0015660899

• Чистая прибыль
• EBITDA
• Активы
• Капитал
• Чистый долг / EBITDA
• Общий долг / Капитал
• Выручка
• Рентабельность по EBITDA (%)